BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · 23分钟前
BioCryst Announces Full Exercise of Underwriters Option to Purchase Additional Shares and Completion of Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire · 15小时前
65 Biggest Movers From Yesterday
Gainers ARCA biopharma, Inc. (NASDAQ: ABIO) shares climbed 386.3% to close at $19.21 on Thursday after the company announced the development program for its AB201 treatment of coronavirus associated with coagulopathy.
Benzinga · 4天前
BioCryst to Present at Jefferies Virtual Healthcare Conference
GlobeNewswire · 4天前
48 Stocks Moving In Thursday's Mid-Day Session
Gainers ARCA biopharma, Inc. (NASDAQ: ABIO) shares jumped 207.6% to $12.15 after the company announced the development program for its AB201 treatment of coronavirus associated with coagulopathy.
Benzinga · 4天前
TWTR, HPQ among premarket losers
Seeking Alpha - Article · 4天前
28 Stocks Moving in Thursday's Pre-Market Session
Gainers
Benzinga · 5天前
BioCryst Pharma Late Wed. Priced ~18.7M Share Offering At $4.50/Share